| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |